معرفی
Hamid Ghandehari is a Distinguished Professor at the University of Utah, holding dual appointments as Chair of Molecular Pharmaceutics and Professor of Biomedical Engineering. His research focuses on nanomedicine and drug delivery systems, particularly using recombinant polymers and silica nanoparticles for targeted therapies in cancer and inflammatory diseases.
- B.S., University of Utah
- Ph.D., University of Utah
His work spans recombinant protein polymers (e.g., SELPs for tumor delivery and embolization), silica nanoconstructs (evaluating toxicity and biocompatibility), chronic rhinosinusitis (liposomal corticosteroid delivery), and ECMO drug adsorption (PEGylation and micellar strategies). Recent studies include HPV+ cancer fluorescence imaging and nanoparticle toxicology.
Research trends highlight ECMO pharmacokinetics (2023-2025), nanoparticle immunotoxicology (2023-2025), oncotherapeutics (2020-2024), and inflammatory disease targeting (2017-2024). Collaborations extend to Otolaryngology and Pediatrics.
- Scientific Awards: Distinguished Professor
